MMP9 and retinoblastoma: Using inhibitors of MMP-2 (ARP100) and MMP-9 (AG-L-66085), the migration in metastatic Y79 retinoblastoma cells was inhibited [56], demonstrating that MMP-2 and MMP-9 could promote Y79 cancer cell migration.